loading
Precedente Chiudi:
$6.41
Aprire:
$6.43
Volume 24 ore:
2.70M
Relative Volume:
1.15
Capitalizzazione di mercato:
$1.88B
Reddito:
$9.47B
Utile/perdita netta:
$-178.00M
Rapporto P/E:
-13.46
EPS:
-0.48
Flusso di cassa netto:
$1.01B
1 W Prestazione:
+4.53%
1M Prestazione:
+40.74%
6M Prestazione:
-15.56%
1 anno Prestazione:
-6.24%
Intervallo 1D:
Value
$6.375
$6.81
Intervallo di 1 settimana:
Value
$5.925
$6.81
Portata 52W:
Value
$3.96
$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
Nome
Bausch Health Companies Inc
Name
Telefono
514-744-6792
Name
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
Dipendente
20,700
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
BHC's Discussions on Twitter

Confronta BHC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
6.46 1.88B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
17.40 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.17 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.38 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.10 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.76 20.17B 16.54B -1.64B 749.00M -1.45

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-02 Downgrade Piper Sandler Neutral → Underweight
2024-07-10 Iniziato Raymond James Mkt Perform
2023-09-20 Aggiornamento Jefferies Hold → Buy
2023-06-16 Downgrade TD Cowen Outperform → Market Perform
2022-07-29 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-07-29 Downgrade Truist Buy → Hold
2022-07-28 Downgrade JP Morgan Overweight → Neutral
2022-06-13 Ripresa JP Morgan Overweight
2021-03-24 Downgrade BofA Securities Neutral → Underperform
2021-02-17 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2021-01-22 Downgrade Piper Sandler Overweight → Neutral
2020-09-17 Aggiornamento BofA Securities Underperform → Neutral
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-17 Reiterato H.C. Wainwright Buy
2020-04-24 Iniziato Citigroup Buy
2020-04-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-29 Downgrade Wolfe Research Outperform → Peer Perform
2020-01-22 Aggiornamento Wells Fargo Underweight → Equal Weight
2019-12-12 Aggiornamento JP Morgan Neutral → Overweight
2019-12-02 Iniziato Goldman Neutral
2019-10-25 Iniziato Cowen Outperform
2019-09-12 Iniziato Guggenheim Buy
2019-08-15 Aggiornamento TD Securities Hold → Buy
2019-07-19 Iniziato Wolfe Research Outperform
2019-06-11 Ripresa Barclays Overweight
2019-05-13 Aggiornamento JP Morgan Underweight → Neutral
2019-03-20 Iniziato SunTrust Buy
2019-01-02 Aggiornamento Piper Jaffray Neutral → Overweight
2018-11-05 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2018-09-13 Aggiornamento Piper Jaffray Underweight → Neutral
Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

pulisher
Jun 18, 2025

Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Bausch Health ticks higher following large director stock purchase - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 17, 2025
pulisher
Jun 16, 2025

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Director buying at Bausch Health Companies (BHC) - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 15, 2025

Bausch Health Companies Inc. (TSE:BHC) Director John Paulson Acquires 754,134 Shares - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Yahoo Finance

Jun 14, 2025
pulisher
Jun 14, 2025

LOOK: These 10 Stocks Just Stole The Show - Insider Monkey

Jun 14, 2025
pulisher
Jun 13, 2025

Bausch Health (BHC) Rises After Director's $15M Share Purchase - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Bausch Health Companies Stock Price, Quotes and Forecasts | NYSE:BHC - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

Hedge Fund and Insider Trading News: Philippe Laffont, Warren Buffett, Bill Ackman, Farallon Capital, Bausch Health Companies Inc (BHC), MicroStrategy Inc (MSTR), and More - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Rising Demand in Traveler's Diarrhea MarketTop Developments, - openPR.com

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Benzodiazepine Drugs Market Trends, Growth Forecast, and Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com

Jun 10, 2025
pulisher
Jun 06, 2025

Huntington's Disease Market Grows with Increased Genetic - openPR.com

Jun 06, 2025
pulisher
Jun 04, 2025

Reconstructive Surgery Market Trends, Size & Growth Forecast - openPR.com

Jun 04, 2025
pulisher
Jun 02, 2025

The most oversold and overbought stocks on the TSX - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Boosts Holdings in Bausch Health Companies Inc. (NYSE:BHC) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Why Is Bausch (BHC) Down 13% Since Last Earnings Report? - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

Intraocular Lens Market Is Booming So Rapidly 2025-2032 -Bausch - openPR.com

May 29, 2025
pulisher
May 29, 2025

With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Choroidal Neovascularization Market: Insights Into Retinal - openPR.com

May 29, 2025
pulisher
May 28, 2025

Verteporfin Market Projected to Witness Increased UtilizationNovartis, Valeant Pharmaceuticals - openPR.com

May 28, 2025
pulisher
May 28, 2025

Actinic Keratosis Market Poised Boom | Almirall, S.A, Bausch - openPR.com

May 28, 2025
pulisher
May 27, 2025

Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Bausch Health’s $7.9 Billion Refinancing Transaction - Global Legal Chronicle

May 26, 2025
pulisher
May 26, 2025

Zacks Research Has Bearish Forecast for BHC Q2 Earnings - Defense World

May 26, 2025
pulisher
May 24, 2025

Research Analysts Offer Predictions for TSE:BHC Q2 Earnings - Defense World

May 24, 2025
pulisher
May 24, 2025

Equities Analysts Set Expectations for BHC Q3 Earnings - Defense World

May 24, 2025
pulisher
May 22, 2025

Colonoscopy Bowel Preparation Drugs Market Detailed Analysis - openPR.com

May 22, 2025
pulisher
May 21, 2025

Facial Injectable Market Forecasts Report 2025-2030, - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Bausch Health Companies IncEnters Agreements With Icahn, Paulson, Kavanagh GroupsSEC Filing - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Bausch Health and Bausch + Lomb Brief: Cos Have Cited Amendment to Definitive Proxy Statement Relating to 2025 Annual Meeting of Shareholders On May 21, 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Bausch + Lomb’s New Board Agreements Announced - TipRanks

May 21, 2025
pulisher
May 21, 2025

Bausch Health Signs New Board Agreements - TipRanks

May 21, 2025
pulisher
May 21, 2025

Bausch Health Companies Inc. (NYSE:BHC) Receives Average Rating of “Reduce” from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Bausch Health Companies (TSE:BHC) Stock Price Up 1.4% – Time to Buy? - Defense World

May 20, 2025
pulisher
May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com | FinancialContent - FinancialContent

May 19, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Invests $97,000 in Bausch Health Companies Inc. (NYSE:BHC) - Defense World

May 19, 2025
pulisher
May 16, 2025

Global Cataract Surgery Devices Market to grow at a CAGR of 5.50% - openPR.com

May 16, 2025
pulisher
May 16, 2025

Bausch Health Companies Inc. (NYSE:BHC) Stake Lessened by Stifel Financial Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Bausch, Mylan Settle Patent Suit Over Generic IBS Drugs - Law360

May 15, 2025
pulisher
May 15, 2025

Bausch Health’s CFO Steps In as Interim CAO - TipRanks

May 15, 2025
pulisher
May 15, 2025

India Ophthalmic Devices Market Forecast Report 2025-2033, - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Genital Herpes Treatment Market reached US$ 1,143.19 million - openPR.com

May 15, 2025

Bausch Health Companies Inc Azioni (BHC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$14.29
price down icon 0.07%
$9.01
price down icon 1.21%
$125.42
price down icon 1.02%
$284.27
price up icon 0.06%
drug_manufacturers_specialty_generic RDY
$15.07
price down icon 1.70%
$16.76
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):